GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
3.540
-0.260 (-6.84%)
At close: Jun 27, 2025, 4:00 PM
3.451
-0.089 (-2.51%)
After-hours: Jun 27, 2025, 7:34 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $11.14 million as of June 27, 2025. Its market cap has increased by 64.04% in one year.
Market Cap
11.14M
Enterprise Value
8.78M
1-Year Change
64.04%
Ranking
Category
Stock Price
$3.54
Market Cap Chart
Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $11.14M, a decrease of -98.81%. That is a compound annual growth rate of -10.08%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 696.15B |
| Johnson & Johnson | 366.71B |
| AbbVie | 322.03B |
| Novo Nordisk | 304.96B |
| UnitedHealth Group | 280.41B |
| Novartis AG | 235.85B |
| Abbott Laboratories | 233.80B |
| AstraZeneca | 220.36B |